Federal Register / Vol. 72, No. 97 / Monday, May 21, 2007 / Notices 28513 

Time: June 29, 2007, 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza, 10 Thomas Circle 

NW., Washington, DC 20005. 

Contact Person: William J Johnson, PhD, 

Scientific Review Administrator, Review 

Branch/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7178, Bethesda, MD 20892–7924, 301–435–

0725, johnsonw@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center For 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: May 14, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2489 Filed 5–18–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Research on Drug Marketing and Social 

Dimensions of Street Drugs. 

Date: May 31, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Avenue, NW., Washington, DC 

200036. 

Contact Person: Gerald L. McLaughin, PhD, 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Blvd., Bethesda, MD 

20892–8401, 301–402–6626, gm145@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Extinction Learning and Pharmacotherapies 

of Drug Addiction/Extinction and 

Pharmacotherapies. 

Date: July 2, 2007. 

Time: 8:30 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Rita Liu, PhD, Associate 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 212, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, 301–

435–1388, rliu@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Centers 

Review Committee. 

Date: July 16, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel at Pentagon City, 

1250 South Hayes Street, Arlington, VA 

22202. 

Contact Person: Rita Liu, PhD, Associate 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 212, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, 301–

435–1388, rliu@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Program 

Projects. 

Date: July 17, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel at Pentagon City, 

1250 South Hayes Street, Arlington, VA 

22202. 

Contact Person: Rita Liu, PhD, Associate 

Director, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 212, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, 301–

435–1388, rliu@nida.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: May 14, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2487 Filed 5–18–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings. 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Aging Special Emphasis Panel, Koo P01 

Teleconference. 

Date: June 7, 2007. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (Telephone Conference 

Call). 

Contact Person: Louise L Hsu, PhD, Health 

Scientist Administrator, Scientific Review 

Office, National Institute on Aging, Gateway 

Building, 7201 Wisconsin Avenue/Suite 

2C212, Bethesda, MD 20892 (301) 496–7705, 

hsul@exmur.nia.nih.gov. 

Name of Committee: National Institute of 

Aging Special Emphasis Panel, AVV–NGF 

TRIAL. 

Date: June 7, 2007. 

Time: 5 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Ramesh Vemuri, PhD, 

Scientific Review Office, National Institute 

on Aging, National Institutes of Health,7201 

Wisconsin Avenue, Suite 2C–212, (301) 402–

7700, rv23r@nia.nih.gov. 

Name of Committee: National Institute of 

Aging Special Emphasis Panel, MOR P01–A2 

Review. 

Date: June 11, 2007. 

Time: 11:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (Telephone Conference 

Call). 

Contact Person: Jon E. Rolf, PhD, Scientific 

Review Administrator, Scientific Review 

Office, National Institute on Aging, Bethesda, 

MD 20814, (301) 402–7703, rolfj@nia.nih.gov. 

Name of Committee: National Institute of 

Aging Special Emphasis Panel, U01 Drug 

Study. 

Date: June 18, 2007. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (Telephone Conference 

Call). 

Contact Person: Louise L. Hsu, PhD, Health 

Scientist Administrator, Scientific Review 


pwalker on PROD1PC71 with NOTICES